Nipt denied for failing step therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for nipt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied NIPT Under Step Therapy

A step-therapy denial for non-invasive prenatal testing (NIPT) means UHC's policy requires that a less advanced or less costly prenatal screening test be attempted (and fail to provide adequate clinical information) before NIPT will be covered. In practice this most often means UHC expects first-trimester serum screening, a nuchal translucency ultrasound, or a quad-screen to be completed and documented prior to approving NIPT — or that those modalities are required for patients in lower-risk categories before NIPT is available.

Step-therapy requirements for diagnostic and screening tests are increasingly scrutinized under state and federal step-therapy reform laws. For prescription drugs, many states have enacted step-therapy override protections; check whether your state's law extends those protections to laboratory tests and whether your plan is subject to state law (fully insured plans generally are; self-funded ERISA plans generally are not).

## Federal Appeal Framework

• ACA §2719 external review: for fully insured non-grandfathered plans, independent external review is available after internal exhaustion. Your denial letter will state the exact deadline.
• ERISA §503 full-and-fair review: governs self-funded plans after internal exhaustion.
• State step-therapy override: if your plan is fully insured and your state has enacted a step-therapy override law, you may have a parallel state-law exception pathway — consult your state insurance commissioner's resources or a patient advocate.
• Expedited review: request if gestational timing makes standard timelines clinically inadequate.

## Appeal Process and Timeline

1. Obtain UHC's NIPT coverage policy and identify the specific prior-step test(s) required. 2. Determine whether any prior screen was already completed — if so, gather that documentation; if not, confirm with the ordering clinician whether completing the prior step is clinically appropriate given gestational age. 3. File a Level 1 internal appeal within the deadline on your denial notice, arguing either (a) the prior step was completed and failed to provide adequate information, or (b) a clinical exception applies.

## Documentation to Gather

• Prior screening records: results of any serum screen, nuchal translucency measurement, or quad-screen already performed, with dates and clinical interpretation.
• Clinical exception documentation: if a prior step was not completed because it was clinically contraindicated, not feasible at the current gestational age, or inadequate for the clinical indication, document that specifically in the chart.
• Ordering provider letter: addresses whether the required prior step was completed, and if not, explains the clinical reason for proceeding directly to NIPT, citing the applicable professional society guidance (ACOG/SMFM).
• Guideline reference: current ACOG/SMFM guidance on which clinical scenarios support proceeding directly to NIPT without a prior serum screen.

## Criteria-Mapping Structure

For a step-therapy appeal, the criteria table has two layers: (1) the step-therapy override criteria — map each to the chart evidence or clinical exception; and (2) the underlying NIPT coverage criteria — map each to the clinical facts. If your appeal rests on a clinical exception to the step-therapy requirement, address it explicitly and cite the guideline organization by name as support.